BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18684281)

  • 1. Leisure-time activities of patients with ICDs: findings of a survey with respect to sports activity, high altitude stays, and driving patterns.
    Kobza R; Duru F; Erne P
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):845-9. PubMed ID: 18684281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological and clinical problems in young adults with implantable cardioverter-defibrillators.
    Wójcicka M; Lewandowski M; Smolis-Bak E; Szwed H
    Kardiol Pol; 2008 Oct; 66(10):1050-8; discussion 1059-60. PubMed ID: 19006026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors related to driving in persons with an implantable cardioverter defibrillator.
    Craney JM; Powers MT
    Prog Cardiovasc Nurs; 1995; 10(3):12-7. PubMed ID: 7479657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of heart rhythm society members.
    Lampert R; Cannom D; Olshansky B
    J Cardiovasc Electrophysiol; 2006 Jan; 17(1):11-5. PubMed ID: 16426392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Restrictions for ICD patients in daily life].
    Köbe J; Gradaus R; Zumhagen S; Böcker D
    Herz; 2005 Nov; 30(7):625-9. PubMed ID: 16333589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avoidance behaviors in patients with implantable cardioverter defibrillators.
    Lemon J; Edelman S; Kirkness A
    Heart Lung; 2004; 33(3):176-82. PubMed ID: 15136777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it safe to allow patients with implantable cardioverter-defibrillators to drive? Learnings from a single center experience.
    Curnis A; Mascioli G; Bontempi L; Cerini M; Bignotti T; Bonetti G; Dei Cas L
    J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1241-5. PubMed ID: 19001931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The implantable defibrillator and return to operation of vehicles study.
    Mylotte D; Sheahan RG; Nolan PG; Neylon MA; McArdle B; Constant O; Diffley A; Keane D; Nash PJ; Crowley J; Daly K
    Europace; 2013 Feb; 15(2):212-8. PubMed ID: 22968849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Driving of a motor vehicle after implantation of a cardioverter-defibrillator in malignant heart rhythm disorders. Criteria for the medical assessment of driving fitness in Europe].
    Lüderitz B; Jung W
    Dtsch Med Wochenschr; 1996 Feb; 121(5):119-23. PubMed ID: 8717193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs and quality-of-life effects of implantable cardioverter-defibrillators.
    Groeneveld PW; Matta MA; Suh JJ; Heidenreich PA; Shea JA
    Am J Cardiol; 2006 Nov; 98(10):1409-15. PubMed ID: 17134641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes, problems and quality of life with the implantable cardioverter defibrillator.
    Reid SS; McKinley S; Nagy S
    Aust J Adv Nurs; 1999; 16(4):14-9. PubMed ID: 10603767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can people with Raynaud's phenomenon travel to high altitude?
    Luks AM; Grissom CK; Jean D; Swenson ER
    Wilderness Environ Med; 2009; 20(2):129-38. PubMed ID: 19594214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Driving restrictions for arrhythmia patients--with special reference to the implantable cardioverter/defibrillator].
    Lüderitz B; Jung W
    Z Kardiol; 1996; 85 Suppl 6():115-21. PubMed ID: 9064955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sexual dysfunction, depression and quality of life in male implantable cardioverter defibrillator (ICD) recipients--with and without shock delivery].
    Shiyovich A; Ben Zion IZ; Plakht Y; Amit G; Grosbard A; Katz A
    Harefuah; 2007 Aug; 146(8):594-8, 647. PubMed ID: 17853553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical function of patients with implantable cardioverter-defibrillators.
    Kim JS; Pressler SJ; Welch JL; Damush T; Sloan RS; Wu J; Groh WJ
    J Cardiovasc Nurs; 2009; 24(5):398-409. PubMed ID: 19707100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
    Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
    Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-assisted computerized education for recipients of implantable cardioverter defibrillators: a randomized controlled trial of the PACER program.
    Kuhl EA; Sears SF; Vazquez LD; Conti JB
    J Cardiovasc Nurs; 2009; 24(3):225-31. PubMed ID: 19390340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No long-term psychological morbidity living with an implantable cardioverter defibrillator under advisory: the Medtronic Marquis experience.
    Birnie DH; Sears SF; Green MS; Lemery R; Gollob MH; Amyotte B
    Europace; 2009 Jan; 11(1):26-30. PubMed ID: 19010798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life and driving in recipients of the implantable cardioverter-defibrillator.
    Jung W; Lüderitz B
    Am J Cardiol; 1996 Sep; 78(5A):51-6. PubMed ID: 8820836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
    Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.